FDA.reportPublic FDA data

Avastin Purple Book BLA 125085

BLA number
125085
Proprietary names
Avastin
Proper names
bevacizumab
Applicant
Genentech, Inc.
Center
CDER
First observed release
2020-02-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
22 patents listed; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Avastinbevacizumab351(a)100MG/4ML (25MG/ML)InjectionIntravenousSingle-Dose VialRxLicensed2004-02-26YES
002Avastinbevacizumab351(a)400MG/16ML (25MG/ML)InjectionIntravenousSingle-Dose VialRxLicensed2004-02-26YES

Biosimilar And Interchangeable Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761028Mvasibevacizumab-awwb351(k) BiosimilarRx2026-06-01
761099Zirabevbevacizumab-bvzr351(k) BiosimilarRx2026-06-01
761175Jobevnebevacizumab-nwgd351(k) BiosimilarRx2026-06-01
761198Avzivibevacizumab-tnjn351(k) BiosimilarRx2026-06-01
761231Alymsysbevacizumab-maly351(k) BiosimilarRx2026-06-01
761268Vegzelmabevacizumab-adcd351(k) BiosimilarRx2026-06-01

Published Patent List#

Patent, Expiration, Source updated table
PatentExpirationSource updated
10,336,9832035-07-312025-06-11
10,208,3552035-07-142025-06-11
10,274,4662035-07-112025-06-11
9,441,0352034-04-232025-06-11
10,017,7322034-03-142025-06-11
10,676,7102034-03-142025-06-11
10,829,7322034-03-142025-06-11
10,906,9342033-10-122025-06-11
10,513,6972032-09-172025-06-11
9,487,8092032-01-142025-06-11
10,704,0712031-08-182025-06-11
10,662,2372031-08-072025-06-11
10,011,8562031-05-262025-06-11
8,512,9832031-01-042025-06-11
10,982,0032030-08-062025-06-11
9,714,2932030-08-062025-06-11
8,460,8952029-08-082025-06-11
10,906,9862028-07-082025-06-11
11,078,2942028-07-082025-06-11
8,574,8692028-07-082025-06-11
7,485,7042025-03-082025-06-11
9,795,6722024-05-282025-06-11

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2021-03-01U001Avastin351(a)RxGenentech, Inc.
2021-03-01U002Avastin351(a)RxGenentech, Inc.
2020-08-01U001Avastin351(a)RxGenentech, Inc.
2020-08-01U002Avastin351(a)RxGenentech, Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-05-01001Avastin351(a)RxLicensed2004-02-26
2020-05-01002Avastin351(a)RxLicensed2004-02-26
2020-02-01001Avastin351(a)MarketedLicensed2004-02-26
2020-02-01002Avastin351(a)MarketedLicensed2004-02-26